🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
613 medicines starting with “T”
MedicineActive substanceLicence holderStatus
Teicoplanin 200 mg Powder and Solvent for Solution for injection/infusion or oral solution
PA1122/009/001
Teicoplanin Noridem Enterprises Limited Marketed
Teicoplanin 400 mg Powder and Solvent for Solution for injection/infusion or oral solution
PA1122/009/002
Teicoplanin Noridem Enterprises Limited Marketed
Teicoplanin Hikma 100 mg powder for solution for injection/infusion
PA1217/010/003
Teicoplanin Hikma Farmacêutica (Portugal) S.A.
Teicoplanin Hikma 200 mg Powder for solution for injection/infusion or oral solution
PA1217/010/001
Teicoplanin Hikma Farmacêutica (Portugal) S.A. Not marketed
Teicoplanin Hikma 400 mg Powder for solution for injection/infusion or oral solution
PA1217/010/002
Teicoplanin Hikma Farmacêutica (Portugal) S.A. Not marketed
Teicoplanin Seacross 200 mg powder for solution for injection/infusion or oral solution
PA22766/011/001
Teicoplanin Seacross Pharma (Europe) Limited Not marketed
Teicoplanin Seacross 400 mg powder for solution for injection/infusion or oral solution
PA22766/011/002
Teicoplanin Seacross Pharma (Europe) Limited Not marketed
Telfast 120 mg film-coated tablets
PA23180/003/002
Fexofenadine hydrochloride Opella Healthcare France SAS T/A Sanofi Marketed
Telfast 180 mg film-coated tablets
PA23180/003/003
Fexofenadine hydrochloride Opella Healthcare France SAS T/A Sanofi Marketed
Telfast 30 mg film-coated tablets
PA23180/003/001
Fexofenadine hydrochloride Opella Healthcare France SAS T/A Sanofi Not marketed
Telfast Allergy 120 mg film-coated tablets
PA23180/014/001
Fexofenadine hydrochloride Opella Healthcare France SAS T/A Sanofi Marketed
Telmisartan 20 mg tablets
PA22749/012/001
Telmisartan Brillpharma (Ireland) Limited Not marketed
Telmisartan 20 mg Tablets
PA2315/014/001
Telmisartan Accord Healthcare Ireland Ltd. Marketed
Telmisartan 40 mg tablets
PA22749/012/002
Telmisartan Brillpharma (Ireland) Limited Not marketed
Telmisartan 40 mg Tablets
PA2315/014/002
Telmisartan Accord Healthcare Ireland Ltd. Marketed
Telmisartan 80 mg tablets
PA22749/012/003
Telmisartan Brillpharma (Ireland) Limited Not marketed
Telmisartan 80 mg Tablets
PA2315/014/003
Telmisartan Accord Healthcare Ireland Ltd. Marketed
Telmisartan Actavis 20 mg tablets
EU/1/10/639/001-010
Telmisartan Actavis Group hf
Telmisartan Actavis 40 mg tablets
EU/1/10/639/011-020
Telmisartan Actavis Group hf
Telmisartan Actavis 80 mg tablets
EU/1/10/639/021-030
Telmisartan Actavis Group hf
Telmisartan Clonmel 20 mg film-coated tablets
PA0126/228/001
Telmisartan Clonmel Healthcare Ltd Marketed
Telmisartan Clonmel 40 mg film-coated tablets
PA0126/228/002
Telmisartan Clonmel Healthcare Ltd Marketed
Telmisartan Clonmel 80 mg film-coated tablets
PA0126/228/003
Telmisartan Clonmel Healthcare Ltd Marketed
Telmisartan Fair-Med 20 mg Tablets
PA1789/008/001
Telmisartan Fairmed Healthcare GmbH Not marketed
Telmisartan Fair-Med 40 mg Tablets
PA1789/008/002
Telmisartan Fairmed Healthcare GmbH Not marketed
Telmisartan Fair-Med 80 mg Tablets
PA1789/008/003
Telmisartan Fairmed Healthcare GmbH Not marketed
Telmisartan Rowa 20 mg tablets
PA0074/078/001
Telmisartan Rowa Pharmaceuticals Limited, Marketed
Telmisartan Rowa 40 mg tablets
PA0074/078/002
Telmisartan Rowa Pharmaceuticals Limited, Marketed
Telmisartan Rowa 80 mg tablets
PA0074/078/003
Telmisartan Rowa Pharmaceuticals Limited, Marketed
Telmisartan Teva Pharma 20 mg tablets
EU/1/11/719/001-020
Telmisartan Teva B.V.
Telmisartan Teva Pharma 40 mg tablets
EU/1/11/719/021-040
Telmisartan Teva B.V.
Telmisartan Teva Pharma 80 mg tablets
EU/1/11/719/041-060
Telmisartan Teva B.V.
Telmisartan/Hydrochlorothiazide 40 mg/12.5 mg tablets
PA2315/107/001
Telmisartan, Hydrochlorothiazide Accord Healthcare Ireland Ltd. Marketed
Telmisartan/Hydrochlorothiazide 80 mg/12.5 mg tablets
PA2315/107/002
Telmisartan, Hydrochlorothiazide Accord Healthcare Ireland Ltd. Marketed
Telmisartan/Hydrochlorothiazide 80 mg/25 mg tablets
PA2315/107/003
Telmisartan, Hydrochlorothiazide Accord Healthcare Ireland Ltd. Marketed
Telmisartan/Hydrochlorothiazide Clonmel 40 mg/12.5 mg tablets
PA0126/259/001
Telmisartan, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Telmisartan/Hydrochlorothiazide Clonmel 80 mg/12.5 mg tablets
PA0126/259/002
Telmisartan, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Telmisartan/Hydrochlorothiazide Clonmel 80 mg/25 mg tablets
PA0126/259/003
Telmisartan, Hydrochlorothiazide Clonmel Healthcare Ltd Marketed
Telmisartan/Hydrochlorothiazide Liconsa 40 mg/12.5 mg tablets
PA1239/025/001
Telmisartan, Hydrochlorothiazide Laboratorios Liconsa S.A. Not marketed
Telmisartan/Hydrochlorothiazide Liconsa 80 mg/12.5 mg tablets
PA1239/025/002
Telmisartan, Hydrochlorothiazide Laboratorios Liconsa S.A. Not marketed
Telmisartan/Hydrochlorothiazide Liconsa 80 mg/25 mg tablets
PA1239/025/003
Telmisartan, Hydrochlorothiazide Laboratorios Liconsa S.A. Not marketed
Telmisartan/Hydrochlorothiazide Rowa 40 mg/12.5 mg tablets
PA0074/081/001
Telmisartan, Hydrochlorothiazide Rowa Pharmaceuticals Limited, Marketed
Telmisartan/Hydrochlorothiazide Rowa 80 mg/12.5 mg tablets
PA0074/081/002
Telmisartan, Hydrochlorothiazide Rowa Pharmaceuticals Limited, Marketed
Telmisartan/Hydrochlorothiazide Rowa 80 mg/25 mg tablets
PA0074/081/003
Telmisartan, Hydrochlorothiazide Rowa Pharmaceuticals Limited, Marketed
Temgesic 200 microgram Sublingual Tablets
PA23460/001/001
Buprenorphine hydrochloride Eumedica Pharmaceuticals GmbH Not marketed
Temgesic 300 micrograms/ml, solution for injection
PA23460/001/002
Buprenorphine hydrochloride Eumedica Pharmaceuticals GmbH Not marketed
Temodal 2.5 mg/ml powder for solution for infusion
EU/1/98/096/023
Temozolomide Merck Sharp & Dohme BV
Temomedac 100 mg hard capsules
EU/1/09/605/5-6
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temomedac 140 mg hard capsules
EU/1/09/605/7-8
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
Temomedac 180 mg hard capsules
EU/1/09/605/9-10
Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH
1 2 3 4 5 6 7

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.